Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bluetongue Viruses Based on Modified-Live Vaccine Serotype 6 with Exchanged Outer Shell Proteins Confer Full Protection in Sheep against Virulent BTV8

25 Sept 2012

Abstract excerpt

Since 1998, Bluetongue virus (BTV)-serotypes 1, 2, 4, 9, and 16 have invaded European countries around the Mediterranean Basin. In 2006, a huge BT outbreak started after incursion of BTV serotype 8 (BTV8) in North-Western Europe. IN 2008, BTV6 and BTV11 were reported in the Netherlands and Germany, and in Belgium, respectively. In addition, Toggenburg orbivirus (TOV) was detected in 2008 in Swiss goats, which was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Vector-Borne Animal Diseases
Share to Viral Infections and Vectors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23049753
DOI: 10.1371/journal.pone.0044619

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bluetongue Viruses Based on Modified-Live Vaccine Serotype 6 with Exchanged Outer Shell Proteins Confer Full Protection in Sheep against Virulent BTV8PMID 23049753Read ↗

Rescue of recent virulent and avirulent field strains of bluetongue virus by reverse genetics.Semantic proximity Read ↗

Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.Semantic proximity Read ↗

Viral Vector Vaccines against Bluetongue VirusSemantic proximity Read ↗

Genetic modification of Bluetongue virus by uptake of "synthetic" genome segmentsSemantic proximity Read ↗

Bluetongue virus: virology, pathogenesis and immunitySemantic proximity Read ↗

Rapid Generation of Replication-Deficient Monovalent and Multivalent Vaccines for Bluetongue Virus: Protection against Virulent Virus Challenge in Cattle and SheepSemantic proximity Read ↗

Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challengeSemantic proximity Read ↗

Characterization of bluetongue virus serotype 28Semantic proximity Read ↗

The MVA-VP2-NS1-2A-NS2-Nt vaccine candidate provides heterologous protection in sheep against bluetongue virusSemantic proximity Read ↗

Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus VaccinesSemantic proximity Read ↗

Development and Evaluation of a Novel Vaccines against Bluetongue Virus Serotype 4 (BTV4)Semantic proximity Read ↗

Generation of Replication-Defective Virus-Based Vaccines That Confer Full Protection in Sheep against Virulent Bluetongue Virus ChallengeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.